Although mutations in SMPD3 affect ~5% of acute myeloid leukemia and acute lymphocytic leukemia patients, mutations were found in only 1/279 (0.4%) tumors in the TCGA head and neck cancer dataset, with copy number variations present in only 3/279 (1%) [21]. Here, SMPD3 is linked to acute myeloid leukemia.